Literature DB >> 28895565

Prostate cancer: CTC phenotype informs treatment type.

Louise Stone.   

Abstract

Entities:  

Year:  2017        PMID： 28895565     DOI： 10.1038/nrurol.2017.151

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.

Authors:  Howard I Scher; Ryon P Graf; Nicole A Schreiber; Brigit McLaughlin; Adam Jendrisak; Yipeng Wang; Jerry Lee; Stephanie Greene; Rachel Krupa; David Lu; Pascal Bamford; Jessica E Louw; Lyndsey Dugan; Hebert A Vargas; Martin Fleisher; Mark Landers; Glenn Heller; Ryan Dittamore
Journal:  Cancer Res       Date:  2017-08-17       Impact factor: 12.701
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.